Close

Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Alexion and DHL Partner for 100% Sustainable Aviation Fuel

Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL...

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...
  • 02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK.
  • MHRA has issued an advisory asking people with an allergic history to refrain from vaccination.

An air of apprehension is doing rounds as this week sees the UK administering the much-awaited Pfizer COVID vaccine shots to its citizens. Two days on and the first warning signal has been issued by British Healthcare regulator asking people with a history of allergies not to take the vaccine. This advisory came to the fore as two NHS healthcare workers suffered allergic reactions to the first jab.

Since this has taken place, an advisory has been floated by MHRA to people who are easily susceptible to medicines, food, and vaccines. These allergic reactions were however not seen across the sample size during the extensive clinical trials that were conducted. The two healthcare workers developed an anaphylactoid reaction shortly after they were administered the COVID-19 vaccine. Although they are stable now, yet a few eyebrows are already raised doubting the prolonged effects of the vaccine. The reactions caused due to anaphylactoid mostly appear as skin rashes, breathlessness and a dip in the blood pressure.

Pfizer has confirmed that they have been advised by the MHRA about the two yellow card reports and are giving the agency all the required support in the investigation.

Latest stories

Related stories

Alexion and DHL Partner for 100% Sustainable Aviation Fuel

Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL...

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back